Citation 145825

SLOLEY,BD: URICHUK,LJ: MORLEY,P: DURKIN,J: SHAN,JJ: PANG,PKT: COUTTS,RT:. (2000). IDENTIFICATION OF KAEMPFEROL AS A MONOAMINE OXIDASE INHIBITOR AND POTENTIAL NEUROPROTECTANT IN EXTRACTS OF GINKGO BILOBA LEAVES.. 52(4)

Citation Details

Title	IDENTIFICATION OF KAEMPFEROL AS A MONOAMINE OXIDASE INHIBITOR AND POTENTIAL NEUROPROTECTANT IN EXTRACTS OF GINKGO BILOBA LEAVES.
Authors	SLOLEY,BD: URICHUK,LJ: MORLEY,P: DURKIN,J: SHAN,JJ: PANG,PKT: COUTTS,RT:
Year	2000
Volume	52
Issue	4

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	PELARGONIDINDAIDZEIN	ACTIVE
2	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	PELARGONIDIN	WEAK ACTIVITY
3	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
4	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETINNARINGENINDAIDZEIN	INACTIVE
5	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	WEAK ACTIVITY
6	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
7	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	ACTIVE
8	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE

Ginkgo biloba (GINKGOACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	MONOAMINE OXIDASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
6	SEROTONIN (5-HT) LEVEL INCREASE	PHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTED	RHAMNETIN,ISO:KAEMPFEROL	None
8	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
9	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
10	MONOAMINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	KAEMPFEROL	INACTIVE
11	NOREPINEPHRINE LEVEL INCREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
12	NEUROPROTECTANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
13	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO:	ACTIVE

Show SPARQL Queries (1)